A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics

pharmacytimes.org/on-demand/a-managed-care-review-of-unmet-medical-needs-new-treatments-and-health-economics-associated-with-schizophrenia-supplement

Related Videos

Related Content

Advertisement

December 11th 2024

Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data

Giuliana Grossi

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition, with key research presented on immune thrombocytopenia, hemophilia, and multiple myeloma.

December 5th 2024

Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas

Brooke McCormick

On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.

December 11th 2024

Elacestrant Shows Real-World Effectiveness in Metastatic Breast Cancers

Cameron Santoro

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction in disease progression or death compared with standard-of-care endocrine therapy.

November 27th 2024

Operationalizing Bispecifics in Multiple Myeloma

Mary Caffrey Laura Joszt, MA

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.

December 11th 2024

Cilta-Cel Leads to Prolonged Progression-Free Survival in Multiple Myeloma

Pearl Steinzor

Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients with multiple myeloma.

December 11th 2024

October 7 Hamas Terrorist Attack Exacerbated MS Severity

Karen Jacobson-Sive

War-related psychological stress was associated with increased MRI-detected disease activity in patients with multiple sclerosis (MS).

Related Content

Advertisement

December 11th 2024

Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data

Giuliana Grossi

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition, with key research presented on immune thrombocytopenia, hemophilia, and multiple myeloma.

December 5th 2024

Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas

Brooke McCormick

On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.

December 11th 2024

Elacestrant Shows Real-World Effectiveness in Metastatic Breast Cancers

Cameron Santoro

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction in disease progression or death compared with standard-of-care endocrine therapy.

November 27th 2024

Operationalizing Bispecifics in Multiple Myeloma

Mary Caffrey Laura Joszt, MA

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.

December 11th 2024

Cilta-Cel Leads to Prolonged Progression-Free Survival in Multiple Myeloma

Pearl Steinzor

Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients with multiple myeloma.

December 11th 2024

October 7 Hamas Terrorist Attack Exacerbated MS Severity

Karen Jacobson-Sive

War-related psychological stress was associated with increased MRI-detected disease activity in patients with multiple sclerosis (MS).